Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test

This document is an administrative notice (Response to Comments) regarding MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test (DL37822) and provides comment and notice period dates. It does not contain clinical coverage, indication, limitation, documentation, or frequency criteria; refer to the referenced LCD (DL37822) for the substantive coverage policy. Extraction confidence is high because no clinical criteria are present in the provided text.